You say “I keep an eagle eye on the science and management. Both are world class”, but what does this even mean at this point? How does one keep an eagle eye on the science when we haven’t had an update on trial progress in around 6 months? What is there to keep an eye on unless you are privy to information that the average shareholder isn’t?
I tend to agree on the comment regarding management (or more accurately for me, the overall team behind imugene), but they need to put some runs on the board soon. Just IMO of course.
You say “I keep an eagle eye on the science and management. Both...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $424.5M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.6¢ | $1.032M | 18.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90000 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 744737 | 5 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
0.000 ( 1.03 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.6¢ | 4924782 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| IMU (ASX) Chart |